Program Directors

Robert Brodsky, MD, Program Director, Professor of Medicine and Oncology - Aplastic anemia, paroxysmal noctural hemoglobinuria (PNH), and other bone marrow failure disorders

Carol Greider, PhD, Program Co-Director, Professor of Molecular Biology and Genetics - Telomere function, the regulation of telomere length and the biochemistry of telomerase

Richard Jones, MD, Program Co-Director, Professor of Oncology, Medicine, and Pathobiology - Hematopoiesis, blood and marrow transplantation, hematologic malignancies

Program Faculty

Richard Ambinder, MD, PhD, Professor of Oncology - Treatment of lymphoma and Kaposi's sarcoma and in development of new strategies for prevention of lymphoma.  Treatment of Hodgkin's disease

Mary Armanios, MD, Assistant Professor of Oncology - Syndromes of telomere shortening which capture both the degenerative and cancer-prone phenotypes of aging

Jef Boeke, PhD, Professor of Molecular Biology and Genetics - Retrotransposition mechanism and its regulation of retrotransposition at several levels, genetic, molecular, biochemical, bioinformatic, and in several systems, yeast, human cells, and in silico

James Casella, MD, Professor of Pediatrics and Oncology - Cellular and molecular basis of pediatric blood-borne diseases, inherited blood disorders, hemophilia, stroke, sickle cell

Linzhao Cheng, PhD, Professor of Medicine - Human stemcell biology and engineering, hematopoiesis (blood-forming)

Andrew Feinberg, MD, MPH, Professor of Molecular Medicine, Medicine, Oncology, and Molecular Biology and Genetics - Epigenetics and DNA methylation, genomic imprinting, cancer biology, genomic Imprinting

Thomas Kickler, MD, Professor of Medicine, Oncology, and Pathology - Hemostasis and platelet disorders

Mark Levis, MD, PhD, Associate Professor of Oncology and Medicine - Identify and validate novel molecular therapeutic targets in hematopoietic malignancies, identification and preclinical development of novel targeted therapies

William Matsui, MD, Associate Professor of Oncology - Cancer stem cells

Michael McDevitt, MD, PhD, Assistant Professor - Evaluation of anemias, thromocytopenias, and general benign hematology

Alison Moliterno, MD, Assistant Professor of Medicine - Myeloproliferative disorders, thrombocytopenia, hypercoaguable states

Linda Resar, MD, Associate Professor of Medicine, Oncology, and Pediatrics - The molecular mechanisms leading to cancer, blood diseases in young adults, sickle cell anemia and other hemoglobinopathies, hemophilia and other coagulopathies

Gregg Semenza, MD, PhD, Professor of Pediatrics, Medicine, Oncology, and Radiation Oncology - Molecular mechanisms underlying angiogenesis and vascular remodeling in ischemic cardiovascular disease and cancer 

Saul Sharkis, PhD, Professor of Oncology - Bone marrow and stem cell transplantation

Jerry Spivak, MD, Professor of Medicine and Oncology - The chronic myeloproliferative disorders, polycythemia vera, idiopathic myelofibrosis, essential thrombocytosis, hypereosinophilia, stocytosis; erythrocytosis and erythropoietin physiology

Advisory Committee Members

Adult Hematology:  Robert Brodsky, MD, Linzhao Cheng, PhD, Linda Resar, MD

Diversity Committee:  Enid Neptune, MD

Hematologic Malignancies:  Richard Jones, MD, Richard Ambinder, MD, PhD

Molecular Biology and Genetics:  Carol Greider, PhD

Molecular Medicine:  Andrew Feinberg, MD, MPH